Martingale Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $209K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $468K | Buy |
|
|||||
|
2023
Q1 | $864K | Buy |
|
|||||
|
2022
Q4 | $971K | Buy |
|
|||||
|
2022
Q3 | $891K | Buy |
|
|||||
|
2022
Q2 | $743K | Buy |
|
|||||
|
2022
Q1 | $1.1M | Buy |
|
|||||
|
2021
Q4 | $1.15M | Sell |
|
|||||
|
2021
Q3 | $1.73M | Buy |
|
|||||
|
2021
Q2 | $855K | Hold |
|
|||||
|
2021
Q1 | $958K | Buy |
|
|||||
|
2020
Q4 | $759K | Sell |
|
|||||
|
2020
Q3 | $1.87M | Buy |
|
|||||
|
2020
Q2 | $488K | Buy |
|